Trimethaphan Production Cost Reports

The report provides detailed analysis essential for establishing a trimethaphan production plant. It encompasses all critical aspects necessary for trimethaphan production, including the cost of trimethaphan production, trimethaphan plant cost, trimethaphan production costs, and the overall trimethaphan production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a trimethaphan production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.

Trimethaphan Market Analysis: Demand and Supply Analysis, and Sourcing

Trimethaphan, also spelled trimetaphan, is a short-acting ganglionic blocking drug given by intravenous infusion. It blocks nicotinic acetylcholine receptors in autonomic ganglia, which cuts both sympathetic and parasympathetic outflow. Blood vessels relax, blood pressure falls, heart rate may rise, and the effect fades within minutes once the drip stops. Leo Sternbach, later famous for the benzodiazepines, discovered it at Hoffmann-La Roche, and Roche sold it as Arfonad. Chemically, trimethaphan is a sulfonium salt, so it carries a permanent positive charge, stays mostly outside cells, and does not cross the blood-brain barrier. Pharmacopeias, labels, and catalogs use the camsylate salt, also called camsilate, camphorsulfonate, or trimetaphan camsilate.

Its classic uses were controlled hypotension during neurosurgery, hypertensive emergencies & dissecting aortic aneurysm. Doctors also used it for acute pulmonary edema and, in older reports, for surgery in children and for priapism. Sodium nitroprusside, nitroglycerin, labetalol, esmolol, nicardipine & clevidipine have since replaced it in almost every setting. Arfonad 50 mg/mL injection, approved under NDA 008983 before modern electronic records, appears on the FDA list of discontinued drug products. We found no current branded supply in the US. Hospital pharmacies, anesthesia departments, and critical care units now stock other drugs for the same jobs.

Supply today comes mainly from research chemical and reference standard houses. TargetMol lists trimethaphan camsylate through CymitQuimica, and Enamine lists 5 mg at $480, marked temporarily unavailable. ChemicalBook lists Chinese firms such as Jiangxi Baicao Pharmaceutical, Shaanxi Dideu Medichem & Henan Rane Chemical, for non-medical research use. Buyers are pharmacology labs, analytical labs & teaching groups that need small, well-documented lots. A trimethaphan demand and supply analysis has to weigh research orders, reference standard needs, the cost of small GMP campaigns, and the slim chance of clinical revival.

Summary of the Product, Grades, and Uses

The trimethaphan cation has the molecular formula C22H25N2OS? and a molar mass of 365.52 g/mol. Trimethaphan camsylate, the drug substance, has the formula C32H40N2O5S2, a molar mass of 596.80 g/mol, and CAS number 68-91-7. Its EINECS number is 200-696-8, its ATC code is C02BA01, and Roche's development code was Nu-2222. Structurally, the cation is a bicyclic sulfonium fused to a 1,3-dibenzyl cyclic urea, built on the same fused ring system, stereochemistry, and sulfur position as biotin. Its camphorsulfonate counter-ion comes from the dextrorotatory form of camphor-10-sulfonic acid, a cheap, stable, and widely used resolving agent.

Trimethaphan camsylate forms white, bitter crystals or crystalline powder with a slight odor. On heating, it decomposes near 245 degree Celsius rather than melting cleanly. Its optical rotation is about +22.0° at 20 degree Celsius, measured at 4 g per 100 mL in water, and serves as a key identity test. About 1 g dissolves in less than 5 mL of water or 2 mL of alcohol, and it is only slightly soluble in acetone and ether. A 1% water solution has a pH of 5.0 to 6.0.

Trimethaphan is now sold in two working grades, each for a different buyer. Reference and research grade, sold in milligram-to-gram lots, serves pharmacology, receptor binding & analytical work. Pharmaceutical grade, made under GMP for injection, would only be needed for a revived product, a clinical study, or a compounding source. Historic injections held 500 mg in 10 mL ampules, which were diluted before infusion. Buyers check assay by HPLC, related substances, optical rotation, water, residual solvents & counter-ion content.

Main End-Uses of Trimethaphan

Research use is now the core end-use for trimethaphan, through pharmacology labs, physiology groups, universities & contract research organizations. Scientists use it to block autonomic ganglia in animal and human studies, separating reflex effects from direct drug effects. Some autonomic physiology studies still use short infusions to test baroreflex function. Such studies need clean, well-characterized material. Receptor biology groups use it as a nicotinic antagonist in ganglion and cell models. Such buyers order milligrams to a few grams, often once a year, and usually from catalogs.

Analytical and reference uses are the second end-use for trimethaphan, in QC labs, forensic labs, and pharmacopoeial work. Labs need a characterized reference standard for identity, assay & impurity testing. Method developers use it to study sulfonium compounds, camphorsulfonate salts, and charged analytes by HPLC and mass spectrometry. Teaching labs use it to show ganglionic blockade in classic pharmacology courses. Few other compounds serve this role as neatly. Orders are tiny, but they need full certificates of analysis, spectra, and purity data.

Clinical use is the smallest end-use for trimethaphan today. In the past, anesthetists infused it to lower blood pressure during brain surgery and to cut bleeding in the operating field. Doctors also used it in aortic dissection, where it lowers pressure without raising the force of each heartbeat as much as some direct vasodilators. Any new clinical use would need a fresh supply chain and a new regulatory filing. No company has announced such a plan, and none appears likely soon.

Trimethaphan Market Risks

Trimethaphan faces the risks of a discontinued, low-volume drug with no active commercial sponsor. Demand depends on research budgets and is small, irregular & hard to forecast. Few producers hold any process knowledge, so supply can vanish when one research chemical firm drops the item. Newer antihypertensive drugs are safer, easier to titrate, and widely available. Side effects include postural hypotension, tachycardia, blurred vision, gut paralysis, urinary retention & histamine release. Rare cases of sudden respiratory arrest have also been reported. Any revival would face a costly regulatory path, a small market, and strong competition.

Manufacturing risks come from the long route, chirality, Grignard chemistry & salt purity. Its cyclic urea core carries several fixed stereocenters, and the wrong isomer would give inactive, mixed, or off-spec product. Grignard reactions need dry solvents, inert gas, clean magnesium, and careful control of heat. Hydrogen bromide in acetic acid is corrosive and toxic. It also attacks steel, gaskets, and many seals. Sulfonium salts can lose an alkyl group on heating or in strong base, which forms thioether impurities. Most failed batches trace back to assay, optical rotation, related substances, color, or residual solvents.

Trimethaphan Production Process and Main Cost Drivers

The trimethaphan production process runs from the biotin thiolactone and 3-ethoxypropyl bromide through Grignard addition, dehydration, hydrogenation, ring closure to the sulfonium bromide with hydrogen bromide, anion exchange to the camphorsulfonate, crystallization, drying, and packing.

1. By Grignard Addition to the Biotin Thiolactone and Sulfonium Ring Closure: The main inputs are the dibenzyl biotin thiolactone, 3-ethoxypropyl bromide, magnesium, ether or tetrahydrofuran, benzene or toluene, acetic acid, hydrogen, Raney nickel or palladium catalyst, hydrogen bromide, d-camphor-10-sulfonic acid or its salt & crystallization solvents.

Trimethaphan production starts with the thiolactone used in the classic Roche biotin synthesis. Chemists describe it as a 1,3-dibenzyl cyclic urea fused to a tetrahydrothiophenone ring, with cis ring fusion, fixed stereocenters, and benzyl protection on both nitrogens. Its ring system comes from meso-diaminosuccinic acid chemistry, a phosgene ring closure, an anhydride, a lactone & a sulfur exchange step. A recent biotin patent made the thiolactone from the lactone with potassium thioacetate in dimethylacetamide at 150 degree Celsius for one hour, in 85% yield. Biotin makers produce this class of intermediate at large scale, which is the main reason trimethaphan can still be made at reasonable cost.

A Goldberg and Sternbach patent for Roche sets out the rest of the chemistry. A Grignard reagent made from 3-ethoxypropyl bromide and magnesium adds to the thiolactone to give a hydroxy thiophane. Refluxing acetic acid removes water and gives the alkylidene compound, a step the patent reports as quantitative. Raney nickel or palladium then hydrogenates the double bond at room temperature and normal pressure over about 30 hours. Heating the 3-ethoxypropyl thiophane in 18% hydrogen bromide in acetic acid at 60 degree Celsius for three hours closes the sulfonium ring. From this step comes the dibenzyl trimethylene thiophanium bromide, melting at 220 to 222 degree Celsius. Exchange with d-camphorsulfonate, followed by crystallization, gives trimethaphan camsylate. Grignard yield, hydrogenation time, and salt purity set most of the conversion cost.

Main Factors Affecting Trimethaphan Production Cost

Trimethaphan production cost is shaped mainly by the thiolactone and the small batch scale. By stoichiometry, each kilogram of trimethaphan camsylate needs about 0.57 kg of the thiolactone, 0.28 kg of 3-ethoxypropyl bromide & 0.39 kg of camphorsulfonic acid. It also needs about 0.04 kg of magnesium in theory. Real use is higher, since the Grignard and salt steps lose material. Losses at the Grignard, hydrogenation, ring closure, and crystallization steps all add up. Being a specialty biotin intermediate, the thiolactone is the costliest input. Camphorsulfonic acid is a common resolving agent and easy to buy.

Small campaigns, labor, testing & documentation drive the rest. Even a gram or kilogram campaign carries the same validation, cleaning, review, and release work as a much larger batch. Grignard and hydrogenation steps need trained staff and dedicated equipment time. Release testing covers HPLC assay, related substances, optical rotation, water, residual solvents & camphorsulfonate content. GMP batch records, stability data, and audits add high fixed cost per kilogram. Reference standard grades add extra purification and characterization work. Price per gram therefore stays high even though the chemistry is not exotic. Buyers pay for documentation as much as for chemistry.

Raw Materials for Trimethaphan Production Plant and its Procurement

Raw material sourcing for trimethaphan centers on the biotin thiolactone, with 3-ethoxypropyl bromide, magnesium & camphorsulfonic acid alongside. Large biotin producers in China and Europe run thiolactone chemistry, but few sell the intermediate on the open market. Fine chemical firms in China and India can make it on request. 3-Ethoxypropyl bromide comes from specialty halide makers in China, India, and Europe, usually in drums or bottles. Magnesium turnings, acetic acid, and hydrogen bromide come from chemical distributors. Camphorsulfonic acid is sold by resolving agent and fine chemical suppliers in China, India, and Europe.

Input quality decides stereochemical purity, yield & color. Buyers require the thiolactone to have the correct cis configuration, high assay, low water, and very low levels of other isomers. 3-Ethoxypropyl bromide must be dry and low in dibromide and alcohol impurities. Camphorsulfonic acid must be the correct enantiomer, with high optical purity. Contracts for trimethaphan inputs set limits on assay, isomer content, water, and residual solvents. Each lot is sampled, tested, logged, and released before use. Holding a backup thiolactone source protects any campaign from delay.

Sustainability and Regulatory Requirements

Trimethaphan manufacture raises environmental duties around ethers, aromatic solvents, magnesium salts & hydrogen bromide. Grignard steps use flammable ethers, need dry nitrogen, and produce magnesium salt waste. Benzene in the original patent should be replaced by toluene or other safer solvents. Hydrogen bromide and acetic acid vents need acid scrubbers, caustic make-up, and regular checks. Spent hydrogenation catalysts, kept wet and sealed, go to metal recovery, while solvent waste goes to incineration. Small campaigns keep the total environmental load low, though each step still needs proper waste segregation, labeling, and disposal.

Regulatory duties for trimethaphan depend on the end use. Research and reference grades are sold for non-medical use and do not need drug approval. A revised US injection could use an abbreviated application only if FDA confirms that Arfonad was not withdrawn for safety or effectiveness reasons. Otherwise, a full application with new chemistry, manufacturing, and controls data would be needed. Any GMP campaign must follow ICH Q7, ICH Q3A, Q3C & Q3D, and sterile injection rules for the finished product. Any new label would need to warn about postural hypotension, histamine release, and rare respiratory arrest.

CAPEX and OPEX for a Trimethaphan Production Plant

A trimethaphan plant is a small multi-purpose fine chemical suite. The trimethaphan plant setup cost begins with glass-lined or stainless reactors of 50 to 500 liters for the Grignard, dehydration, and sulfonium steps. For the double bond reduction, a small pressure-rated hydrogenator with catalyst filters, gas lines, and safety interlocks is enough. Filters, dryers & a crystallizer complete the train, along with glovebox or isolator space for weighing. Corrosion-resistant equipment is needed for hydrogen bromide in acetic acid. Utilities cover nitrogen, chilled brine, steam, vacuum, hydrogen, and scrubbers. On the QC side, the lab holds HPLC, LC-MS, a polarimeter, Karl Fischer, GC for solvents, and NMR for structure confirmation.

Trimethaphan operating cost is led by the thiolactone, labor, testing, and documentation. Solvents, magnesium, catalysts & camphorsulfonic acid add steady variable costs. Fixed costs cover equipment time, cleaning validation, quality systems, and stability programs. Any sterile injection would add contract filling, sterility testing, endotoxin testing, and stability studies. Sharing the suite with biotin-related intermediates and other small APIs brings the cost per kilogram down. Running several years of demand in one campaign also helps. Stored material must then be retested before each sale.

Plant Location and Investment Factors

A workable trimethaphan site sits near biotin intermediate makers or inside a fine chemical cluster with Grignard and hydrogenation skills. China's Zhejiang, Jiangsu & Shandong provinces host biotin producers and custom synthesis firms. India's Hyderabad and Gujarat clusters offer low-cost custom synthesis. Europe and the US suit GMP reference standard work and any revived injection. Good sites offer dry solvent handling, hydrogen safety, acid scrubbing, waste incineration, and strong analytical support.

For a trimethaphan project, the first investment decision is the target market. Research and reference supply needs only small, well-documented batches. Reviving clinical use would need GMP API, sterile fill, stability data, and a full filing. Make or buy for the thiolactone is the second decision. Buying from a biotin producer is far cheaper than building the full route. Product range, from one compound to a full catalog of rare drugs, is the third decision. Trimethaphan alone cannot carry a plant. Trimethaphan fits only as a catalog item in a custom synthesis, reference standard, or research chemical business.

Major Trimethaphan Producing Regions

China is the main source of trimethaphan today, through research chemical firms such as Jiangxi Baicao Pharmaceutical, Shaanxi Dideu Medichem, Henan Rane Chemical & Chongqing Jooe. China also hosts large biotin producers that make the key thiolactone class of intermediates. The US hosts TargetMol's catalog business and many end users in pharmacology research. Ukraine-based Enamine offers milligram lots through its catalog. Switzerland and the US hold the historic Roche development and Arfonad approval. India and Europe can supply custom synthesis and GMP work on request. Lead times for such orders often run to several months.

Key Trimethaphan Producers

Hoffmann-La Roche

• Swiss pharmaceutical group that discovered and developed trimethaphan.
• Held NDA 008983 for Arfonad 50 mg/mL injection, now on the FDA's discontinued list.
• Leo Sternbach and Moses Goldberg patented the related sulfonium chemistry for Roche.
• No longer markets the product in the US.

TargetMol

• Research chemical supplier serving biology and drug discovery labs.
• Lists trimethaphan camsylate as a nicotinic antagonist and ganglionic blocker.
• Competes on a large bioactive compound catalog & quick delivery.
• Sells through distributors such as CymitQuimica.

Enamine

• Kyiv-based supplier of building blocks, screening compounds & reference materials.
• Lists trimethaphan camsylate in its impurity and reference section at $480 for 5 mg.
• Competes on synthesis capacity, catalog breadth & custom chemistry.
• Showed the item as temporarily unavailable at the time of review.

Shaanxi Dideu Medichem

• Chinese fine chemical and pharmaceutical intermediate supplier based in Xi'an.
• Listed on ChemicalBook as a supplier of trimethaphan camsylate.
• Competes on low-cost custom synthesis & broad catalog listings.
• Supplies research and industrial customers in China and abroad.

Jiangxi Baicao Pharmaceutical

• Chinese pharmaceutical and fine chemical company in Jiangxi province.
• Listed on ChemicalBook as a trimethaphan camsylate supplier.
• Competes on a Chinese cost base & small-lot supply.
• Sells for research and other non-medical uses.

Henan Rane Chemical

• Chinese chemical supplier based in Henan province.
• Listed on ChemicalBook for trimethaphan camsylate.
• Competes on catalog range, price & export service.
• Serves research and laboratory buyers worldwide.